Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Twenty-two years of candidaemia surveillance: results from a Norwegian national study.

Hesstvedt L, Gaustad P, Andersen CT, Haarr E, Hannula R, Haukland HH, Hermansen NO, Larssen KW, Mylvaganam H, Ranheim TE, Sandven P, Nordøy I; Norwegian Yeast Study Group, Kanestrøm A, Grub C, Onken A, Thielsen C, Skaare D, Tofteland S, Sønsteby LJ, Hjetland R, Hide R, Vik E, Kümmel A, Åsheim S.

Clin Microbiol Infect. 2015 Oct;21(10):938-45. doi: 10.1016/j.cmi.2015.06.008. Epub 2015 Jun 18.

2.

Real-time polymerase chain reaction for detection of low-intensity Schistosoma japonicum infections in China.

Lier T, Simonsen GS, Wang T, Lu D, Haukland HH, Vennervald BJ, Hegstad J, Johansen MV.

Am J Trop Med Hyg. 2009 Sep;81(3):428-32.

PMID:
19706908
3.

Low sensitivity of the formol-ethyl acetate sedimentation concentration technique in low-intensity Schistosoma japonicum infections.

Lier T, Simonsen GS, Wang T, Lu D, Haukland HH, Vennervald BJ, Johansen MV.

PLoS Negl Trop Dis. 2009;3(2):e386. doi: 10.1371/journal.pntd.0000386. Epub 2009 Feb 24.

4.

[How can the use of laboratories be directed?].

Gjelsvik R, Kaarbøe O, Haukland HH, Monsen AL, Sandberg S.

Tidsskr Nor Laegeforen. 2008 Apr 3;128(7):840. Norwegian. No abstract available.

5.

[More adequate use of laboratory services--economical aspects].

Gjelsvik R, Kaarbøe O, Haukland HH, Monsen AL, Sandberg S.

Tidsskr Nor Laegeforen. 2008 Apr 3;128(7):814-7. Norwegian.

6.

[Appropriate use of laboratory tests--medical aspects].

Monsen AL, Gjelsvik R, Kaarbøe O, Haukland HH, Sandberg S.

Tidsskr Nor Laegeforen. 2008 Apr 3;128(7):810-3. Norwegian.

7.

Candidemia in Norway (1991 to 2003): results from a nationwide study.

Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsåker T, Gaustad P; Norwegian Yeast Study Group.

J Clin Microbiol. 2006 Jun;44(6):1977-81.

8.

Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B.

Samuelsen O, Haukland HH, Kahl BC, von Eiff C, Proctor RA, Ulvatne H, Sandvik K, Vorland LH.

J Antimicrob Chemother. 2005 Dec;56(6):1126-9. Epub 2005 Nov 15.

PMID:
16287983
9.

Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus.

Samuelsen O, Haukland HH, Jenssen H, Krämer M, Sandvik K, Ulvatne H, Vorland LH.

FEBS Lett. 2005 Jun 20;579(16):3421-6. Erratum in: FEBS Lett. 2005 Oct 10;579(24):5437.

10.

Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis.

Ulvatne H, Samuelsen Ø, Haukland HH, Krämer M, Vorland LH.

FEMS Microbiol Lett. 2004 Aug 15;237(2):377-84.

11.

Anti-complement effects of lactoferrin-derived peptides.

Samuelsen Ø, Haukland HH, Ulvatne H, Vorland LH.

FEMS Immunol Med Microbiol. 2004 Jun 1;41(2):141-8.

12.

Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B.

Ulvatne H, Haukland HH, Samuelsen Ø, Krämer M, Vorland LH.

J Antimicrob Chemother. 2002 Oct;50(4):461-7.

PMID:
12356789
13.
14.

Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.

Haukland HH, Vorland LH.

J Antimicrob Chemother. 2001 Oct;48(4):569-71.

PMID:
11581240
15.
16.

Antibacterial effects of lactoferricin B.

Vorland LH, Ulvatne H, Andersen J, Haukland HH, Rekdal O, Svendsen JS, Gutteberg TJ.

Scand J Infect Dis. 1999;31(2):179-84.

PMID:
10447329
17.

Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.

Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M.

J Clin Microbiol. 1998 Dec;36(12):3455-9.

18.

Phosphoinositide metabolism in a polyoma-BK-virus-transformed pancreatic islet cell line: evidence for constitutively activated phospholipase C.

Giaever AK, Haukland HH, Bertinussen A, Vonen B, Malm D, Huseby NE, Florholmen J.

Int J Cancer. 1993 Jan 2;53(1):80-6.

PMID:
8380059
19.

Transformed rat pancreatic islet-cell lines established by BK virus infection in vitro.

Haukland HH, Vonen B, Traavik T.

Int J Cancer. 1992 Apr 22;51(1):79-83.

PMID:
1348726
20.

Changes in postprandial release patterns of gastrointestinal hormones in late pregnancy and the early postpartum period.

Jenssen TG, Haukland HH, Vonen B, Florholmen J, Burhol PG, Maltau JM.

Br J Obstet Gynaecol. 1988 Jun;95(6):565-70.

PMID:
2898947
21.

Brain-gut peptides in sauna-induced hyperthermia.

Jenssen TG, Haukland HH, Burhol PG.

Acta Physiol Scand. 1988 Apr;132(4):519-23.

PMID:
2906506
22.

Characterization of secretin-like immunoreactivity in pregnancy.

Jenssen TG, Holst N, Burhol PG, Olsen RL, Haukland HH, Florholmen J, Maltau JM, Hvidsten D.

Gynecol Obstet Invest. 1988;26(2):171-6.

PMID:
3220321
23.

The effect of severe pre-eclampsia on the pancreas: changes in the serum cationic trypsinogen and pancreatic amylase.

Haukland HH, Florholmen J, Oian P, Maltau JM, Burhol PG.

Br J Obstet Gynaecol. 1987 Aug;94(8):765-7.

PMID:
2444246
25.

Effect of proximal gastric vagotomy on insulin- induced gastric H+ and pepsin secretion and serum group I pepsinogens.

Haukland HH, Waldum HL, Johnson JA.

Scand J Gastroenterol. 1982 Jun;17(4):555-9.

PMID:
6813958
26.

Carcinoma diagnosed in excised gastric ulcers.

Haukland HH, Johnson JA, Eide JT.

Acta Chir Scand. 1981;147(6):439-43.

PMID:
6275649

Supplemental Content

Loading ...
Support Center